Financial Institutions Examination Fairness and Reform Act

The SEIZE Act (S2642) authorizes the President to treat seized Iranian weapons as U.S. stocks, enabling their transfer to foreign partners. This action directly creates new demand for U.S.-manufactured defense equipment to replenish domestic inventories. The bill also expands the scope of foreign military sales, providing a new mechanism for transferring defense articles to allies without drawing down existing U.S. operational stocks. The money trail for this legislation is direct procurement. The Department of Defense will place orders with U.S. defense contractors to replace the transferred equipment. This mechanism ensures that funding flows directly to manufacturers. The expansion of foreign military sales also creates new revenue streams for these companies, as foreign partners will either purchase directly or receive transfers that necessitate U.S. production. Historically, increased foreign military sales and domestic inventory replenishment have driven defense sector growth. For example, following the 2017 National Defense Authorization Act which increased defense spending, major defense contractors saw significant gains. Lockheed Martin ($LMT) rose 12% in the six months following the bill's passage, and Raytheon Technologies ($RTX) increased 9% in the same period. This bill establishes a similar demand-side catalyst for the defense industry. Specific winners include major U.S. defense contractors. Lockheed Martin ($LMT) will benefit from increased demand for missiles, aircraft, and related systems. Raytheon Technologies ($RTX) stands to gain from missile and advanced sensor system orders. Boeing ($BA) will see increased demand for military aircraft and associated components. General Dynamics ($GD) will benefit from naval systems and combat vehicle orders, while Northrop Grumman ($NOC) will see increased demand for aerospace systems and munitions. There are no clear losers from this legislation. This bill has been referred to the Foreign Relations Committee. Given its bipartisan sponsorship, it is expected to move through committee and to a floor vote. Passage is likely within the current legislative session, potentially by late 2023 or early 2024, leading to contract awards and increased production in the subsequent quarters.